NCT06143449

Brief Summary

To Investigate the Risk Factors, Life Style and Treatments of the Microvascular Disease，Macrovascular Disease and Neuropathy in Patients With Diabetes.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24,000

participants targeted

Target at P75+ for all trials

Timeline
57mo left

Started Oct 2015

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress70%
Oct 2015Dec 2030

Study Start

First participant enrolled

October 1, 2015

Completed
8.1 years until next milestone

First Submitted

Initial submission to the registry

November 16, 2023

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 22, 2023

Completed
7.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2030

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2030

Last Updated

November 29, 2023

Status Verified

November 1, 2023

Enrollment Period

15.3 years

First QC Date

November 16, 2023

Last Update Submit

November 26, 2023

Conditions

Diabetes Mellitus

Outcome Measures

Primary Outcomes (2)

  • Provide data on patient characteristics

    Ten years

  • Provide data on disease management.

    Ten years

Interventions

Observational study - registryOTHER

Observational study - registry

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with diabetes mellitus

You may qualify if:

  • Diagnosis of diabetes mellitus

You may not qualify if:

  • Patients who do not have diabetes mellitus
  • Participating in an interventional trial requiring informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Diabetes Association of the Republic of China (Taiwan)

Taipei, 10046, Taiwan

RECRUITING

MeSH Terms

Conditions

Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • The Diabetes Association of the Republic of China (Taiwan)

Central Study Contacts

Diabetes Association of the R.O.C

CONTACT

diabetes.tw@gmail.com

Diabetes Association of the R.O.C

CONTACT

diabetes.tdr@gmail.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
10 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 16, 2023

First Posted

November 22, 2023

Study Start

October 1, 2015

Primary Completion (Estimated)

December 31, 2030

Study Completion (Estimated)

December 31, 2030

Last Updated

November 29, 2023

Record last verified: 2023-11

Locations

TW(1)